.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The SELECT2 trial was one of the landmark randomized studies testing endovascular thrombectomy in acute ischemic stroke patients with large infarct cores. Participants with anterior-circulation large-vessel occlusion and low ASPECTS or a large perfusion-defined core were randomized to thrombectomy plus medical therapy or medical therapy alone. The trial showed a favourable shift in functional outcomes with thrombectomy across the study population, supporting the idea that substantial benefit can remain even after a large amount of brain tissue has already infarcted. The findings are important because they challenge the historical exclusion of large-core stroke from reperfusion pathways. For HCPs, the clinical message is not to treat every large-core patient identically. Eligibility still depends on vascular anatomy, imaging, premorbid function, time window and clinical severity. Rapid transfer to a thrombectomy-capable centre remains critical. The study directly supports IANCON's focus on emerging evidence in vascular neurology and the expanding boundaries of mechanical thrombectomy.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The SELECT2 trial was one of the landmark randomized studies testing endovascular thrombectomy in acute ischemic stroke patients with large infarct cores. Participants with anterior-circulation large-vessel occlusion and low ASPECTS or a large perfusion-defined core were randomized to thrombectomy plus medical therapy or medical therapy alone. The trial showed a favourable shift in functional outcomes with thrombectomy across the study population, supporting the idea that substantial benefit can remain even after a large amount of brain tissue has already infarcted. The findings are important because they challenge the historical exclusion of large-core stroke from reperfusion pathways. For HCPs, the clinical message is not to treat every large-core patient identically. Eligibility still depends on vascular anatomy, imaging, premorbid function, time window and clinical severity. Rapid transfer to a thrombectomy-capable centre remains critical. The study directly supports IANCON's focus on emerging evidence in vascular neurology and the expanding boundaries of mechanical thrombectomy.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
